Alluvi tirzepatide appears to have emerged as a promising therapeutic agent for the control of metabolic disorders. This initial evaluation investigated the efficacy and safety of tirzepatide 40mg in experimental models of insulin resistance. The research demonstrated that tirzepatide 40mg significantly elevated glycemic management and decreased in